![Michael Mullette](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Michael Mullette
Società | Posizione | Inizio | Fine |
---|---|---|---|
Lykos Therapeutics PBC
![]() Lykos Therapeutics PBC BiotechnologyHealth Technology Part of Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, Inc. is a public benefit corporation that focuses on developing and commercializing prescription psychedelics to provide better treatments for people with mental health conditions. The private company is based in San Jose, CA. Lykos Therapeutics aims to catalyze healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics, prioritizing public benefit above profit. The company was founded in 2014, and the CEO is Amy Emerson. | Direttore operativo | 01/03/2022 | - |
Storia della carriera di Michael Mullette
Precedenti posizioni note di Michael Mullette
Società | Posizione | Inizio | Fine |
---|---|---|---|
MODERNA, INC. | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Posizioni
Corporate Officer/Principal | 1 |
Chief Operating Officer | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
MODERNA, INC. | Health Technology |
Aziende private | 1 |
---|---|
Lykos Therapeutics PBC
![]() Lykos Therapeutics PBC BiotechnologyHealth Technology Part of Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, Inc. is a public benefit corporation that focuses on developing and commercializing prescription psychedelics to provide better treatments for people with mental health conditions. The private company is based in San Jose, CA. Lykos Therapeutics aims to catalyze healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics, prioritizing public benefit above profit. The company was founded in 2014, and the CEO is Amy Emerson. | Health Technology |
- Borsa valori
- Insiders
- Michael Mullette
- Esperienza